![]() |
| Color-enhanced tissue section from colon of a C. rodentium-infected mouse that displays intestinal inflammation characterized by inflammatory cell infiltrates and crypt elongation. Credit: Gregory F. Sonnenberg, University of Pennsylvania School of Medicine |
Following infection by Citrobacter rodentium -- a model of human E. coli infection in the gut - this cell population was the dominant source of IL-22, a molecule that helps in the immune response during the early phases of infection. When the inducer cells were eliminated from the intestine of the experimental mice, immunity was impaired, affecting the production of anti-microbial proteins required to fight infection. The mice eventually died.
This discovery could also represent a new line of research for HIV/AIDS, says Artis, since there is a breakdown of barrier immunity in the gut (a reservoir for HIV) that can lead to full blown AIDS. Therapeutics to target such immune cells could be an important new way to combat AIDS.
The research was funded by the National Institute of Allergy and Infectious Diseases, the Burroughs Welcome Fund, and the Crohn's and Colitis Foundation of America.
Source: University of Pennsylvania